🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 17 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/07/2010 10,20 10,30 9,72 10,00 -2,91% 5,69% 35.740
01/07/2010 11,00 11,20 9,70 10,30 -6,36% 13,64% 58.410
30/06/2010 10,80 11,10 10,40 11,00 +6,80% 6,48% 27.820
29/06/2010 11,40 11,90 10,30 10,30 -9,65% 14,04% 64.490
28/06/2010 11,80 12,00 11,20 11,40 -3,39% 6,78% 50.240
25/06/2010 11,80 12,50 11,80 11,80 -0,84% 5,93% 66.110
24/06/2010 12,60 12,60 11,80 11,90 -4,80% 6,35% 63.840
23/06/2010 12,70 12,90 12,40 12,50 +0,81% 3,94% 51.560
22/06/2010 12,40 12,80 12,30 12,40 -1,59% 4,03% 39.240
21/06/2010 13,50 13,70 12,30 12,60 -3,08% 10,37% 97.780
18/06/2010 12,70 13,00 12,40 13,00 +5,69% 4,72% 152.710
17/06/2010 16,70 16,70 11,40 12,30 -25,00% 31,74% 415.100
16/06/2010 16,70 17,00 16,00 16,40 -1,80% 5,99% 46.390
15/06/2010 16,70 16,70 16,20 16,70 +0,00% 2,99% 29.220
14/06/2010 17,10 17,10 16,60 16,70 +1,83% 2,92% 19.890
11/06/2010 16,60 17,00 16,10 16,40 -1,20% 5,42% 28.450
10/06/2010 17,20 17,39 16,60 16,60 +2,47% 4,59% 21.860
09/06/2010 16,50 16,90 16,10 16,20 -1,82% 4,85% 30.880
08/06/2010 17,10 17,20 16,20 16,50 -0,60% 5,85% 53.010
07/06/2010 16,30 18,00 16,30 16,60 -10,27% 10,43% 82.860
04/06/2010 16,80 18,50 16,00 18,50 +9,47% 14,88% 156.960
03/06/2010 15,00 17,40 14,81 16,90 +12,67% 17,27% 80.270
02/06/2010 14,50 15,00 14,00 15,00 +1,83% 6,90% 38.790
01/06/2010 14,70 15,20 13,60 14,73 +9,11% 10,88% 57.890
28/05/2010 13,30 13,50 13,00 13,50 +4,65% 3,76% 12.540
27/05/2010 12,70 13,20 12,60 12,90 +3,20% 4,72% 19.610
26/05/2010 12,60 12,99 12,50 12,50 +0,00% 3,89% 15.680
25/05/2010 12,60 12,90 12,50 12,50 -3,10% 3,17% 33.230
24/05/2010 13,10 13,10 12,70 12,90 +1,57% 3,05% 14.580
21/05/2010 12,70 13,00 12,50 12,70 -0,78% 3,94% 33.400